A high-ranking official is endeavoring to reactivate a key advisory committee responsible for informing the government about vaccine-related matters.
A federal court decision is being challenged by the Trump administration, seeking an accelerated review of a ruling that halted several vaccine-related determinations made by Health Secretary Robert F. Kennedy Jr., specifically revoking guidelines for vaccinations against six common childhood illnesses.
Related ↗Prince George set for esteemed education at Eton.The administration has submitted an urgent appeal, as revealed by Mr. Kennedy's recent social media update, aiming for a swift review of the ruling blocking their vaccine policy. This move aims to facilitate a timely meeting of federal advisors to discuss shot recommendations ahead of the upcoming fall flu season.
A lawsuit filed by six prominent medical groups, led by the American Academy of Pediatrics, has escalated with a new development. The complaint alleged that Mr. Kennedy's administration at the CDC unreasonably altered the pediatric vaccination timeline in an arbitrary manner.
Read next ↗Algae infestation prompts emergency response at Reflecting Pool.The committee claims that the panel members selected by Mr. Kennedy lack the necessary expertise to make informed vaccination recommendations, thereby putting the health of American citizens at risk due to their uninformed decisions.
A federal judge's decision on March 16 in Massachusetts halted Mr. Kennedy's policies until the trial concluded, effectively paralyzing his appointed panelists' actions and thwarting the committee's ability to convene at their planned time.
The administration's move to revive the committee is gaining momentum, as evident in Friday's announcement. In response to President Trump's executive order last month, Mr. Kennedy's office took swift action by reinstating the committee's charter, paving the way for alignment with international vaccination standards.
The 2026-2027 respiratory virus season, encompassing RSV, influenza, and Covid, commences in autumn. Due to the A.C.I.P.'s inaction, no newly approved or reformulated vaccines can be incorporated into the immunization schedule during this period. The administration's motion, filed with the U.S. District Court for the District of Massachusetts, presented this argument.
The medical organizations' attorney, Richard Hughes, issued a statement condemning the administration's bid as an "attempt to deflect responsibility" for Secretary Kennedy's actions.
Mr. Hughes expressed strong opposition to expediting the appeal, citing concerns that it would facilitate further detrimental actions by the individual in question.
Historically, recommendations on vaccine use have been crafted by A.C.I.P. members following an exhaustive evaluation of benefits versus potential risks, a deliberative process that can span months or even years. In June last year, Mr. Kennedy made sweeping changes to the committee, replacing all 17 existing members with new appointees who often questioned the efficacy of vaccines.
In a series of intense discussions, the newly appointed panel members revoked multiple guidelines for pediatric vaccinations, specifically targeting mandatory hepatitis B inoculation for newborns, a highly contagious disease known to cause severe liver damage.
In January, without consulting the committee, Dr. Kennedy's appointee at the CDC took an unprecedented step, unveiling a revised vaccination schedule that significantly reduced the number of diseases targeted by routine childhood immunizations from 17 to just 11.
Judge Brian Murphy's ruling highlighted a shift from traditional scientific procedures to inform vaccine policies, as he emphasized the reliance on "procedural requirements" codifying these guidelines.
The administration's approach has been marred by a blatant disregard for established protocols.
The six panelists selected by Mr. Kennedy for A.C.I.P. appear to lack substantial expertise in vaccine matters, a critical aspect of their work.
The Trump administration swiftly responded to the ruling with a plan to challenge it. The Justice Department submitted a request to the court on April 23 to suspend proceedings until an appeal was underway. This move aimed to conserve taxpayer resources and redirect agency personnel from administrative tasks back to critical public health duties. Two days later, on April 29, the administration formally notified the court of its intention to pursue an appeal.
According to Dorit Reiss, a renowned expert in vaccine policy and law at the University of California College of the Law, San Francisco, the administration's decision to appeal may have been prompted by the court's demand for detailed records.
The decision to seek a stay and file an appeal may have been motivated by concerns over revealing sensitive information or the trial's progress, which seemed to be faltering at the time.
